Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 19:11 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
NCT05101356 · University of California, Davis · PHASE1/PHASE2 · suspended · last registry update 2026-06-29 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Drugs unavailable” | – | Registry record, University of California, Davis |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CSF2RA within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-10-30Results posted on the registry: Memorial Sloan Kettering Cancer Center, Hu3F8 + GM-CSF (NCT03033303)
- 2026-10-30Also stopped (terminated): Tufts Medical Center, Granulocyte-Macrophage Colony-Stimulating Factor + Pembrolizumab (NCT04856176)
- 2026-10-09Also stopped (withdrawn): Georgetown University, NY-ESO-1 Peptide vaccine + Toripalimab-tpzi (NCT05479045)
- 2026-08-05Results posted on the registry: Beth Israel Deaconess Medical Center, GM-CSF + Dendritic Cell/Tumor Fusion Vaccine (NCT00799110)
- 2026-08-05Also stopped (terminated): Beth Israel Deaconess Medical Center, GM-CSF + Dendritic Cell/Tumor Fusion Vaccine (NCT00799110)
- 2026-06-30Results posted on the registry: Academic and Community Cancer Research United, Cyclophosphamide + Multi-epitope Folate Receptor Alpha Peptide Vaccine (NCT03012100)
- 2026-05-05Results posted on the registry: Nationwide Children's Hospital, GM-CSF (NCT03769844)
- 2026-04-23Results posted on the registry: University of Florida, TTRNA-DC vaccines with GM-CSF + Dose-intensified TMZ (NCT03334305)
- 2026-04-23Also stopped (terminated): University of Florida, TTRNA-DC vaccines with GM-CSF + Dose-intensified TMZ (NCT03334305)
- 2026-04-03Results posted on the registry: University of Washington, CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine + Sargramostim (NCT05242965)
- 2026-01-21Results posted on the registry: Children's Oncology Group, Dinutuximab + Eflornithine Hydrochloride (NCT03794349)
- 2025-10-29Also stopped (terminated): University of Florida, TTRNA-DC vaccines with GM-CSF + TTRNA-xALT (NCT03396575)
- 2025-08-07Results posted on the registry: Savara Inc., Molgramostim + Placebo (NCT04544293)
- 2025-08-07Also stopped (withdrawn): Mayo Clinic, Aerosol Sargramostim + Nivolumab (NCT05717140)
- 2025-08-06Results posted on the registry: Eli Lilly and Company, Abemaciclib + Irinotecan (NCT04238819)
- 2025-08-06Also stopped (terminated): University of Florida, Autologous DCs derived from PBMC loaded with RNA encoding the human CMV matrix protein pp65-flLAMP plus GM-CSF (NCT04963413)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision